PRKG1 (cGMP-dependent protein kinase 1) variants and mutations
PRKG1 (also known as cGMP-dependent protein kinase 1) is a human protein-coding gene encoding a cGMP-dependent protein kinase 1 protein. It transduces cyclic-GMP signals from nitric oxide and natriuretic peptides to promote vascular smooth-muscle relaxation and regulate vascular tone. A recurrent activating variant causes highly penetrant familial thoracic aortic aneurysm and dissection. This analysis covers 1,048 PRKG1 variants and mutations. Of these, 55% have computational variant effect predictions. Disease context includes familial thoracic aortic aneurysm and aortic dissection, Rare genetic vascular disease, and dengue disease. Example PRKG1 variants include S2N, S2T, and S2R.
Variant analysis overview
- Gene: PRKG1
- Protein: cGMP-dependent protein kinase 1
- UniProt accession: Q13976
- Organism: Homo sapiens
- Variants analyzed: 1048
- Variant scope: all variants
- Completed: 2026-08-18
Variant and mutation evidence
- Variant composition: 838 unspecified-consequence records; 117 missense variants; 68 synonymous variants; 9 frameshift variants; 3 in-frame deletions; 11 stop-gained variants; 1 splice-region variants; 1 in-frame insertions
- Prediction scores: 574 variants have prediction scores (55% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: familial thoracic aortic aneurysm and aortic dissection, Rare genetic vascular disease, dengue disease, smoking initiation, bone remodeling disease, alcohol drinking, cervical carcinoma, placental abruption, ovarian neoplasm, urolithiasis, laryngeal carcinoma, Tinnitus.
Protein structure and variant hotspots
- Protein features: 2 domains; 13 binding sites; 3 post-translational modification sites.
- Structural context: 370 variants have structural context.
- PTM context: 7 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable PRKG1 variants
Examples include S2N, S2T, S2R, E3Q, E3D, E3E, L4P, L4R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2N (p.Ser2Asn), cosmic curated COSV10943, MetaLR 0.20, MetaSVM -0.86
- S2T (p.Ser2Thr), TOPMed rs1842780315, MetaLR 0.14, MetaSVM -0.95
- S2R (p.Ser2Arg), gnomAD 10-50991384-C-G, MetaLR 0.22, MetaSVM -0.83
- E3Q (p.Glu3Gln), gnomAD rs1234312117, MetaLR 0.16, MetaSVM -0.96
- E3D (p.Glu3Asp), gnomAD 10-50991387-G-T, MetaLR 0.11, MetaSVM -1.02
- E3E (p.Glu3Glu), gnomAD 10-50991387-G-A, CADD 13.00
- L4P (p.Leu4Pro), gnomAD rs1025225046, MetaLR 0.43, MetaSVM -0.14
- L4R (p.Leu4Arg), gnomAD rs1025225046, MetaLR 0.46, MetaSVM -0.01
- L4L (p.Leu4Leu), gnomAD 10-50991388-C-T, CADD 13.80
- L4I (p.Leu4Ile), gnomAD 10-50991388-C-A, MetaLR 0.41, MetaSVM -0.07
- E5K (p.Glu5Lys), 1000Genomes rs200844105, ESP rs200844105, ExAC rs200844105, TOPMed rs200844105, MetaLR 0.16, MetaSVM -0.82, Benign
- E5Q (p.Glu5Gln), rs200844105, ClinGen CA5502988, ClinVar RCV001285889, ClinVar RCV003918820, MetaLR 0.13, MetaSVM -0.96, Likely benign, Aortic aneurysm, familial thoracic 8
- E5V (p.Glu5Val), ExAC rs749057103, TOPMed rs749057103, gnomAD rs749057103, MetaLR 0.19, MetaSVM -0.77
- E5E (p.Glu5Glu), gnomAD 10-50991393-G-A, CADD 13.50
- E6* (p.Glu6Ter), NCI-TCGA Cosmic COSV1009, cosmic curated COSV10091, Variant assessed as somatic; high impact.
- E6D (p.Glu6Asp), ExAC rs756992967, TOPMed rs756992967, gnomAD rs756992967, MetaLR 0.13, MetaSVM -0.87
- E6K (p.Glu6Lys), cosmic curated COSV10468, MetaLR 0.23, MetaSVM -0.66
- D7N (p.Asp7Asn), ESP rs376397116, ExAC rs376397116, TOPMed rs376397116, gnomAD rs376397116, MetaLR 0.21, MetaSVM -0.77
- D7Y (p.Asp7Tyr), ESP rs376397116, ExAC rs376397116, TOPMed rs376397116, gnomAD rs376397116, MetaLR 0.30, MetaSVM -0.47
- D7G (p.Asp7Gly), gnomAD 10-50991398-A-G, MetaLR 0.22, MetaSVM -0.66
- D7D (p.Asp7Asp), gnomAD 10-50991399-C-T, CADD 14.30
- D7E (p.Asp7Glu), gnomAD 10-50991399-C-A, MetaLR 0.12, MetaSVM -0.95
- F8C (p.Phe8Cys), rs1842780542, gnomAD 10-50991399-CTT-C, CADD 32.00
- A9V (p.Ala9Val), Ensembl rs1681566712, MetaLR 0.38, MetaSVM -0.37
- A9A (p.Ala9Ala), gnomAD 10-50991405-C-G, CADD 14.30
- K10N (p.Lys10Asn), cosmic curated COSV64868, MetaLR 0.23, MetaSVM -0.72
- K10E (p.Lys10Glu), gnomAD 10-50991406-A-G, MetaLR 0.12, MetaSVM -0.94
- I11T (p.Ile11Thr), ExAC rs745772695, gnomAD rs745772695, MetaLR 0.19, MetaSVM -0.87
- I11I (p.Ile11Ile), gnomAD 10-50991411-T-C, CADD 12.20
- L12I (p.Leu12Ile), NCI-TCGA Cosmic COSV6486, cosmic curated COSV64864, Variant assessed as somatic; moderate impact.
- L12L (p.Leu12Leu), rs771726791, gnomAD 10-50991414-C-A, CADD 12.20
- M13I (p.Met13Ile), rs202017913, ClinGen CA346591, ClinVar RCV000157424, ClinVar RCV001803098, MetaLR 0.15, MetaSVM -0.99, Likely benign, Aortic aneurysm, familial thoracic 8; not provided; Familial thoracic aortic ane
- M13L (p.Met13Leu), NCI-TCGA TCGA novel, MetaLR 0.05, MetaSVM -0.98, Variant assessed as somatic; moderate impact.
- M13T (p.Met13Thr), gnomAD rs1197775380, MetaLR 0.15, MetaSVM -0.89
- M13V (p.Met13Val), gnomAD rs1488048945, MetaLR 0.09, MetaSVM -1.04
- L14F (p.Leu14Phe), rs763460888, ExAC rs763460888, TOPMed rs763460888, gnomAD rs763460888, MetaLR 0.31, MetaSVM -0.26, Variant assessed as somatic; moderate impact.
- L14H (p.Leu14His), TOPMed rs1158758049, gnomAD rs1158758049
- L14I (p.Leu14Ile), gnomAD 10-50991418-C-A, MetaLR 0.22, MetaSVM -0.86
- L14L (p.Leu14Leu), rs1379084523, gnomAD 10-50991420-C-T, CADD 13.40
- K15M (p.Lys15Met), cosmic curated COSV10890
- K15T (p.Lys15Thr), NCI-TCGA TCGA novel, MetaLR 0.13, MetaSVM -0.96, Variant assessed as somatic; moderate impact.
- K15E (p.Lys15Glu), gnomAD 10-50991421-A-G, MetaLR 0.49, MetaSVM 0.17
- E16D (p.Glu16Asp), ExAC rs776134753, gnomAD rs776134753, MetaLR 0.07, MetaSVM -0.98
- E16K (p.Glu16Lys), gnomAD 10-50991424-G-A, MetaLR 0.24, MetaSVM -0.47
- E16G (p.Glu16Gly), gnomAD 10-50991425-A-G, MetaLR 0.20, MetaSVM -0.69
- E16E (p.Glu16Glu), rs878854901, gnomAD 10-51074629-G-A, CADD 14.80
- E16* (p.Glu16Ter), gnomAD 10-51074636-G-T, CADD 39.00
- E16Q (p.Glu16Gln), rs757672025, gnomAD 10-51074636-G-C, REVEL 0.23, MetaLR 0.25
- E17D (p.Glu17Asp), ExAC rs773757054, gnomAD rs773757054, MetaLR 0.19, MetaSVM -0.84
- E17G (p.Glu17Gly), ExAC rs765486540, gnomAD rs765486540, MetaLR 0.33, MetaSVM -0.44
- E17K (p.Glu17Lys), cosmic curated COSV10529, gnomAD rs1295204783, MetaLR 0.35, MetaSVM -0.51, Uncertain significance, Aortic aneurysm, familial thoracic 8
- E17del (p.Glu17del), rs1842780873, gnomAD 10-50991421-AAGG-, CADD 22.30
- E17R (p.Glu17Arg), gnomAD 10-50991425-AG-A, CADD 25.10
- E17* (p.Glu17Ter), gnomAD 10-50991427-G-T, CADD 39.00
- E17E (p.Glu17Glu), rs773757054, gnomAD 10-50991429-G-A, CADD 12.30
- R18K (p.Arg18Lys), gnomAD 10-50991431-G-A, MetaLR 0.31, MetaSVM -0.61
- R18M (p.Arg18Met), gnomAD 10-50991431-G-T, MetaLR 0.41, MetaSVM -0.24
- R18S (p.Arg18Ser), gnomAD 10-50991432-G-T, MetaLR 0.38, MetaSVM -0.38
- R18R (p.Arg18Arg), rs752092723, gnomAD 10-51074603-C-A, CADD 15.10
- R18G (p.Arg18Gly), rs752092723, gnomAD 10-51074603-C-G, REVEL 0.13, MetaLR 0.24
- R18Q (p.Arg18Gln), rs1440365856, gnomAD 10-51074604-G-A, REVEL 0.22, MetaLR 0.18
- I19V (p.Ile19Val), TOPMed rs1226942029, MetaLR 0.25, MetaSVM -0.72
- I19L (p.Ile19Leu), gnomAD 10-51074663-A-C, REVEL 0.16, MetaLR 0.26
- I19S (p.Ile19Ser), gnomAD 10-51074664-T-G, REVEL 0.41, MetaLR 0.49
- I19I (p.Ile19Ile), rs776048746, gnomAD 10-51074665-C-A, CADD 13.30
- K20E (p.Lys20Glu), cosmic curated COSV64879, Ensembl rs1842781045, MetaLR 0.10, MetaSVM -0.97
- K20T (p.Lys20Thr), gnomAD 10-50991437-A-C, MetaLR 0.13, MetaSVM -1.02
- K20N (p.Lys20Asn), gnomAD 10-50991438-A-T, MetaLR 0.15, MetaSVM -1.01
- E21A (p.Glu21Ala), gnomAD 10-50991437-AAG-A, CADD 33.00
- E21K (p.Glu21Lys), gnomAD 10-50991439-G-A, MetaLR 0.22, MetaSVM -0.80
- E21D (p.Glu21Asp), gnomAD 10-50991441-G-T, MetaLR 0.19, MetaSVM -0.87
- L22V (p.Leu22Val), gnomAD 10-50991442-C-G, MetaLR 0.34, MetaSVM -0.40
- L22L (p.Leu22Leu), rs1270920831, gnomAD 10-50991442-C-T, CADD 12.60
- L22R (p.Leu22Arg), gnomAD 10-50991443-T-G, MetaLR 0.47, MetaSVM -0.02
- E23K (p.Glu23Lys), TOPMed rs1842781107, CADD 22.20, SIFT 0.05
- E23Q (p.Glu23Gln), gnomAD 10-50991445-G-C, MetaLR 0.39, MetaSVM -0.45
- E23E (p.Glu23Glu), gnomAD 10-50991447-G-A, CADD 12.60
- K24* (p.Lys24Ter), gnomAD 10-50991448-A-T, CADD 38.00
- K24K (p.Lys24Lys), rs907161119, gnomAD 10-50991450-G-A, CADD 12.70
- R25L (p.Arg25Leu), TOPMed rs1480756312, gnomAD rs1480756312, MetaLR 0.17, MetaSVM -0.86
- R25W (p.Arg25Trp), gnomAD 10-50991451-C-T, MetaLR 0.27, MetaSVM -0.40
- R25R (p.Arg25Arg), rs1002824327, gnomAD 10-50991451-C-A, CADD 13.40
- L26L (p.Leu26Leu), gnomAD 10-50991456-G-A, CADD 13.30
- S27P (p.Ser27Pro), gnomAD 10-50991457-T-C, MetaLR 0.15, MetaSVM -0.99
- S27A (p.Ser27Ala), gnomAD 10-50991457-T-G, MetaLR 0.10, MetaSVM -1.02
- E28G (p.Glu28Gly), Ensembl rs1055837832, MetaLR 0.49, MetaSVM -0.08
- E28Q (p.Glu28Gln), TOPMed rs1242528708, gnomAD rs1242528708, MetaLR 0.16, MetaSVM -1.02
- E28R (p.Glu28Arg), gnomAD 10-50991458-C-CA, CADD 28.10
- E28D (p.Glu28Asp), gnomAD 10-50991462-G-T, MetaLR 0.20, MetaSVM -0.96
- E28E (p.Glu28Glu), rs747149491, gnomAD 10-51074671-G-A, CADD 14.50
- K29del (p.Lys29del), gnomAD 10-50991460-GAGA-, CADD 21.60
- K29* (p.Lys29Ter), gnomAD 10-50991463-A-T, CADD 38.00
- K29N (p.Lys29Asn), gnomAD 10-50991465-G-C, MetaLR 0.21, MetaSVM -0.99
- K29K (p.Lys29Lys), rs763403241, gnomAD 10-50991465-G-A, CADD 10.80
- E30G (p.Glu30Gly), TOPMed rs1842781285, MetaLR 0.20, MetaSVM -0.78
- E30K (p.Glu30Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E30Q (p.Glu30Gln), TOPMed rs1842781251
- E31K (p.Glu31Lys), rs1353068439, ClinGen CA376825549, ClinVar RCV003402476, gnomAD rs1353068439, MetaLR 0.18, MetaSVM -0.89, Uncertain significance, PRKG1-related disorder
- E31V (p.Glu31Val), gnomAD 10-50991470-A-T, MetaLR 0.19, MetaSVM -0.92
- E32* (p.Glu32Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- E32D (p.Glu32Asp), NCI-TCGA Cosmic COSV1009, cosmic curated COSV10091, Variant assessed as somatic; moderate impact.
- E32V (p.Glu32Val), cosmic curated COSV10970
- E32A (p.Glu32Ala), gnomAD 10-50991473-A-C, MetaLR 0.25, MetaSVM -0.60
- I33M (p.Ile33Met), ExAC rs766478650, TOPMed rs766478650, gnomAD rs766478650, MetaLR 0.32, MetaSVM -0.52
- I33T (p.Ile33Thr), gnomAD rs1237616278, MetaLR 0.18, MetaSVM -0.90, Uncertain significance, Familial thoracic aortic aneurysm and aortic dissection; Aortic aneurysm, famili
- I33V (p.Ile33Val), gnomAD 10-50991475-A-G, MetaLR 0.21, MetaSVM -0.83
- I33I (p.Ile33Ile), rs766226389, gnomAD 10-51074707-C-A, CADD 14.70
- Q34R (p.Gln34Arg), gnomAD rs1842781405, MetaLR 0.14, MetaSVM -1.02
- Q34Q (p.Gln34Gln), rs1843898962, gnomAD 10-51074614-G-A, CADD 12.70
- Q34H (p.Gln34His), gnomAD 10-51074692-G-C, REVEL 0.20, MetaLR 0.24
- E35K (p.Glu35Lys), rs372471361, cosmic curated COSV10091, ESP rs372471361, gnomAD rs372471361, MetaLR 0.38, MetaSVM -0.52, Variant assessed as somatic; moderate impact.
- E35E (p.Glu35Glu), rs1189253229, gnomAD 10-51074725-G-A, CADD 13.10
- L36V (p.Leu36Val), TOPMed rs1456395762, gnomAD rs1456395762, MetaLR 0.33, MetaSVM -0.48
- L36L (p.Leu36Leu), rs777040411, gnomAD 10-51074684-T-C, CADD 15.30
- K37K (p.Lys37Lys), gnomAD 10-50991489-G-A, CADD 13.10
- R38M (p.Arg38Met), NCI-TCGA TCGA novel, MetaLR 0.25, MetaSVM -0.61, Variant assessed as somatic; moderate impact.
- R38K (p.Arg38Lys), gnomAD 10-50991491-G-A, MetaLR 0.15, MetaSVM -0.86
- K39N (p.Lys39Asn), gnomAD 10-50991495-A-T, MetaLR 0.17, MetaSVM -1.00
- K39K (p.Lys39Lys), rs1418072211, gnomAD 10-50991495-A-G, CADD 13.00
- L40P (p.Leu40Pro), TOPMed rs1842781531, MetaLR 0.24, MetaSVM -0.72
- L40I (p.Leu40Ile), gnomAD 10-50991496-C-A, MetaLR 0.22, MetaSVM -0.88
- L40L (p.Leu40Leu), gnomAD 10-51074716-G-A, CADD 14.30
- H41R (p.His41Arg), gnomAD 10-50991500-A-G, MetaLR 0.19, MetaSVM -0.82
- K42Q (p.Lys42Gln), gnomAD 10-50991502-A-C, MetaLR 0.49, MetaSVM -0.10
- K42N (p.Lys42Asn), gnomAD 10-50991504-A-C, MetaLR 0.46, MetaSVM -0.24
- K42R (p.Lys42Arg), gnomAD 10-51074712-A-G, REVEL 0.09, MetaLR 0.10
- K42K (p.Lys42Lys), rs146681875, gnomAD 10-51074713-G-A, CADD 14.30
- C43C (p.Cys43Cys), rs1209644631, gnomAD 10-50991507-C-T, CADD 14.40
- Q44R (p.Gln44Arg), rs751572252, ClinGen CA5503002, ClinVar RCV004515229, ExAC rs751572252, MetaLR 0.16, MetaSVM -0.98, Uncertain significance, Familial thoracic aortic aneurysm and aortic dissection
- Q44Q (p.Gln44Gln), gnomAD 10-50991510-G-A, CADD 13.20
- Q44H (p.Gln44His), gnomAD 10-50991510-G-T, MetaLR 0.25, MetaSVM -0.66
- Q44* (p.Gln44Ter), gnomAD 10-51074708-C-T, CADD 37.00
- Q44K (p.Gln44Lys), gnomAD 10-51074717-C-A, REVEL 0.16, MetaLR 0.16
- S45* (p.Ser45Ter), gnomAD rs1178803378
- S45A (p.Ser45Ala), gnomAD rs1458818322, MetaLR 0.21, MetaSVM -0.94
- S45L (p.Ser45Leu), rs1178803378, gnomAD rs1178803378, MetaLR 0.22, MetaSVM -0.91, Variant assessed as somatic; moderate impact.
- S45S (p.Ser45Ser), rs190880830, gnomAD 10-50991513-G-A, CADD 10.20
- V46M (p.Val46Met), TOPMed rs1840857745, MetaLR 0.39, MetaSVM -0.23
- V46R (p.Val46Arg), gnomAD 10-50991511-T-TCG, CADD 32.00
- V46V (p.Val46Val), rs1842781679, gnomAD 10-50991516-G-A, CADD 13.60
- L47F (p.Leu47Phe), gnomAD 10-50991517-C-T, MetaLR 0.14, MetaSVM -1.00
- L47L (p.Leu47Leu), gnomAD 10-50991519-C-T, CADD 10.90
- L47P (p.Leu47Pro), rs767414253, gnomAD 10-51074727-T-C, REVEL 0.49, MetaLR 0.55
- P48A (p.Pro48Ala), NCI-TCGA Cosmic COSV6487, cosmic curated COSV64872, Variant assessed as somatic; moderate impact.
- P48L (p.Pro48Leu), TOPMed rs1842781726, gnomAD rs1842781726, MetaLR 0.27, MetaSVM -0.63
- P48Q (p.Pro48Gln), cosmic curated COSV10091, MetaLR 0.26, MetaSVM -0.70
- P48S (p.Pro48Ser), NCI-TCGA Cosmic COSV6487, Variant assessed as somatic; moderate impact.
- V49G (p.Val49Gly), NCI-TCGA TCGA novel, MetaLR 0.18, MetaSVM -0.90, Variant assessed as somatic; moderate impact.
- V49M (p.Val49Met), TOPMed rs1416776423, gnomAD rs1416776423, MetaLR 0.14, MetaSVM -1.02
- V49L (p.Val49Leu), gnomAD 10-51074744-G-T, REVEL 0.21, MetaLR 0.32
- V49V (p.Val49Val), gnomAD 10-51074746-G-C, CADD 14.00
- P50L (p.Pro50Leu), gnomAD rs1166877299, MetaLR 0.19, MetaSVM -0.74
- P50S (p.Pro50Ser), gnomAD 10-50991526-C-T, MetaLR 0.15, MetaSVM -0.82
- P50H (p.Pro50His), gnomAD 10-50991527-C-A, MetaLR 0.18, MetaSVM -0.82
- P50P (p.Pro50Pro), gnomAD 10-50991528-C-G, CADD 14.90
- S51L (p.Ser51Leu), cosmic curated COSV64867, MetaLR 0.45, MetaSVM -0.04, Uncertain significance, Aortic aneurysm, familial thoracic 8
- S51* (p.Ser51Ter), gnomAD 10-50991530-C-A, CADD 37.00
- S51S (p.Ser51Ser), gnomAD 10-50991531-G-T, CADD 7.81
- S51W (p.Ser51Trp), rs752677774, gnomAD 10-51074742-C-G, REVEL 0.41, MetaLR 0.50
- p.Ser51 Val52insLeuTrpValGlyLysV, gnomAD 10-51074743-G-GCT, CADD 21.90
- T52I (p.Thr52Ile), gnomAD 10-50991533-C-T, MetaLR 0.18, MetaSVM -0.85
- T52T (p.Thr52Thr), rs752863259, gnomAD 10-50991534-C-A, CADD 10.80
- T52S (p.Thr52Ser), gnomAD 10-51074598-C-G, REVEL 0.09, MetaLR 0.17
- H53D (p.His53Asp), ESP rs377518710, ExAC rs377518710, TOPMed rs377518710, gnomAD rs377518710, MetaLR 0.12, MetaSVM -1.01
- H53Y (p.His53Tyr), ESP rs377518710, ExAC rs377518710, TOPMed rs377518710, gnomAD rs377518710, MetaLR 0.11, MetaSVM -1.05
- I54F (p.Ile54Phe), ExAC rs778832051, TOPMed rs778832051, gnomAD rs778832051, MetaLR 0.17, MetaSVM -0.65
- I54M (p.Ile54Met), TOPMed rs1187046446, MetaLR 0.11, MetaSVM -0.96
- I54T (p.Ile54Thr), gnomAD 10-50991539-T-C, MetaLR 0.12, MetaSVM -0.90
- I54I (p.Ile54Ile), gnomAD 10-50991540-C-T, CADD 13.60
- G55R (p.Gly55Arg), ExAC rs745828304, gnomAD rs745828304, MetaLR 0.19, MetaSVM -0.87
- G55D (p.Gly55Asp), gnomAD 10-50991542-G-A, MetaLR 0.20, MetaSVM -0.85
- G55G (p.Gly55Gly), rs531509793, gnomAD 10-50991543-C-A, CADD 12.40
- P56R (p.Pro56Arg), ExAC rs779720584, TOPMed rs779720584, gnomAD rs779720584, MetaLR 0.21, MetaSVM -0.76
- P56T (p.Pro56Thr), NCI-TCGA Cosmic COSV6488, cosmic curated COSV64881, Ensembl rs2132705331, MetaLR 0.23, MetaSVM -0.75, Variant assessed as somatic; moderate impact.
- P56P (p.Pro56Pro), rs746586027, gnomAD 10-50991546-C-G, CADD 3.22
- R57Q (p.Arg57Gln), gnomAD rs1233139477, MetaLR 0.18, MetaSVM -0.65
- R57G (p.Arg57Gly), gnomAD 10-50991542-GC-G, CADD 23.90
- R57R (p.Arg57Arg), rs1341627302, gnomAD 10-50991547-C-A, CADD 14.40
- R57L (p.Arg57Leu), gnomAD 10-50991548-G-T, MetaLR 0.20, MetaSVM -0.74
- R57H (p.Arg57His), rs1382232985, gnomAD 10-51074739-G-A, REVEL 0.23, MetaLR 0.37
Public PRKG1 analysis runs
- PRKG1 analysis run — PRKG1 (1,048 variants) — completed 2026-08-18